Pantoprazole Kalceks

Pantoprazole, the active ingredient in Pantoprazole Kalceks, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑oesophageal reflux disease and related acid‑related disorders in adults.

GNH USA supplies Pantoprazole Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Kalceks is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief of heartburn and promotes healing of erosive esophagitis. - Erosive gastritis: facilitates mucosal healing by reducing gastric acidity. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may present with persistent diarrhoea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fractures: associated with long‑term use. - Liver enzyme elevation: indicates possible hepatic stress.

Before initiating therapy, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term use: assess need for ongoing therapy after 12 months. - Pregnancy and lactation: weigh benefits against potential risks. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines; clinical relevance varies.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (ritonavir, lopinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: modest increase in serum concentration. - Oral contraceptives: slight reduction in efficacy.